| Karen Colleen Carroll, MD | |
|
4940 Eastern Ave, Baltimore, MD 21224-2735 | |
| (410) 955-5077 | |
| Not Available |
| Full Name | Karen Colleen Carroll |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 4940 Eastern Ave, Baltimore, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568410439 | NPI | - | NPPES |
| 413520200 | Medicaid | MD | |
| D59246 | Other | MD | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | D59246 (Maryland) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | D59246 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen Colleen Carroll, MD 9910 Franklin Square Dr # 2110, Baltimore, MD 21236-4902 Ph: () - | Karen Colleen Carroll, MD 4940 Eastern Ave, Baltimore, MD 21224-2735 Ph: (410) 955-5077 |
News Archive
Has your memory failed you today, such as struggling to recall a word that's "on the tip of your tongue?" If so, you're not alone.
Researchers affiliated with the Kawasaki INnovation Gateway at SKYFRONT, have successfully developed a humanized mouse model showing that so-called NK cells that directly attacking tumors, can survive and maintain function in vivo.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Nearly 75 percent of Americans suffer from some form of periodontal disease, the major cause of adult tooth loss. In addition, cardiovascular disease, the leading killer of men and women in the United States, is a major public health issue contributing to 2,400 deaths each day. And while these two conditions are seemingly unrelated, research suggests that managing one disease may reduce the risk for the other.
Endocyte Inc., a company developing targeted small-molecule drug conjugates, will present results of an interim analysis from a randomized phase II clinical trial in women with platinum-resistant ovarian cancer on Sunday (June 6) during the 46th annual meeting of the American Society of Clinical Oncology in Chicago.
› Verified 2 days ago
Serena Maria Bagnasco, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Baltimore, MD 21224 Phone: 410-955-2660 | |
Dr. Adeboye Oluwaseyi Osunkoya, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 N Broadway, Johns Hopkins Pathology , Weinberg Room 2242, Baltimore, MD 21231 Phone: 405-808-5361 | |
Michael T. O'malley, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2401 W Belvedere Ave, Baltimore, MD 21215 Phone: 410-644-4379 Fax: 410-644-4325 | |
Michael Edward Kallen, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 N Broadway St, Baltimore, MD 21287 Phone: 410-955-3580 Fax: 410-614-1287 | |
Deyin Xing, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 North Broadway, Weinberg 2268, Baltimore, MD 21231 Phone: 410-955-3580 Fax: 410-614-1287 | |
Matthew Grant Gabrielson, Pathology Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-3980 | |
Robert A. Palermo, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6701 N Charles St, Baltimore, MD 21204 Phone: 443-849-2257 Fax: 443-849-3016 |